Total Payments
$99,104
2024 Payments
$5,026
Companies
76
Transactions
884
Medicare Patients
9,043
Medicare Billing
$863,446
Payment Breakdown by Category
Research$69,356 (70.0%)
Food & Beverage$26,519 (26.8%)
Travel$1,541 (1.6%)
Gifts$1,215 (1.2%)
Education$473.12 (0.5%)
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Unspecified | $69,356 | 11 | 70.0% |
| Food and Beverage | $26,519 | 851 | 26.8% |
| Travel and Lodging | $1,541 | 7 | 1.6% |
| Gift | $1,215 | 3 | 1.2% |
| Education | $473.12 | 12 | 0.5% |
Payments by Type
Research
$69,356
10 transactions
General
$29,748
873 transactions
Ownership
$0
1 transactions
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| COLOPLAST CORP | $72,554 | 39 | $0 (2024) |
| Boston Scientific Corporation | $5,504 | 114 | $0 (2024) |
| Endo Pharmaceuticals Inc. | $1,892 | 66 | $0 (2023) |
| NxThera, Inc. | $1,792 | 24 | $0 (2018) |
| Medtronic USA, Inc. | $1,579 | 24 | $0 (2019) |
| Medtronic, Inc. | $1,498 | 22 | $0 (2024) |
| Myriad Genetic Laboratories, Inc. | $1,226 | 42 | $0 (2024) |
| Janssen Biotech, Inc. | $1,022 | 47 | $0 (2024) |
| Astellas Pharma US Inc | $1,017 | 48 | $0 (2024) |
| PFIZER INC. | $848.32 | 55 | $0 (2024) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $5,026 | 138 | Boston Scientific Corporation ($792.08) |
| 2023 | $57,736 | 139 | Coloplast Corp ($53,731) |
| 2022 | $21,263 | 114 | Coloplast Corp ($18,041) |
| 2021 | $2,632 | 78 | BOSTON SCIENTIFIC CORPORATION ($1,076) |
| 2020 | $1,686 | 59 | Boston Scientific Corporation ($361.76) |
| 2019 | $3,498 | 131 | Boston Scientific Corporation ($1,090) |
| 2018 | $3,321 | 136 | BOSTON SCIENTIFIC CORPORATION ($995.45) |
| 2017 | $3,941 | 89 | NxThera, Inc. ($1,602) |
All Payment Transactions
884 individual payment records from CMS Open Payments — Page 1 of 36
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 12/21/2024 | Medtronic, Inc. | INTERSTIM (Device) | Food and Beverage | In-kind items and services | $9.21 | General |
| Category: Sacral Nerve Stimulation | ||||||
| 12/19/2024 | Myriad Genetic Laboratories, Inc. | PROLARIS (Device) | Food and Beverage | In-kind items and services | $26.31 | General |
| Category: ONCOLOGY | ||||||
| 12/16/2024 | PFIZER INC. | XTANDI (Drug), ORGOVYX, TALZENNA | Food and Beverage | In-kind items and services | $15.41 | General |
| Category: ONCOLOGY | ||||||
| 12/12/2024 | Sumitomo Pharma America, Inc. | ORGOVYX (Drug) | Food and Beverage | In-kind items and services | $21.41 | General |
| Category: HORMONE THERAPY | ||||||
| 12/07/2024 | Myriad Genetic Laboratories, Inc. | PROLARIS (Device) | Food and Beverage | In-kind items and services | $100.00 | General |
| Category: ONCOLOGY | ||||||
| 12/05/2024 | Boston Scientific Corporation | SpaceOAR VUE System - 10mL (Device) | Food and Beverage | In-kind items and services | $140.44 | General |
| Category: SpaceOAR VUE_URO | ||||||
| 12/05/2024 | Ferring Pharmaceuticals Inc. | ADSTILADRIN (Biological) | Food and Beverage | In-kind items and services | $22.24 | General |
| Category: ONCOLOGY | ||||||
| 12/05/2024 | Boston Scientific Corporation | Rezum Generator (Device) | Food and Beverage | In-kind items and services | $16.85 | General |
| Category: rezum_URO | ||||||
| 12/03/2024 | Dendreon Pharmaceuticals LLC | PROVENGE (Drug) | Food and Beverage | In-kind items and services | $31.68 | General |
| Category: CELLULAR BIOLOGIC TREATMENT FOR PROSTATE CANCER | ||||||
| 12/02/2024 | Endo USA, Inc. | AVEED (Biological), XIAFLEX | Food and Beverage | In-kind items and services | $26.35 | General |
| Category: UROLOGY | ||||||
| 11/27/2024 | PROCEPT BioRobotics Corporation | AQUABEAM SYSTEM (Device) | Food and Beverage | Cash or cash equivalent | $126.09 | General |
| Category: UROLOGY | ||||||
| 11/27/2024 | ABC Home Medical Supply, Inc. | — | Food and Beverage | In-kind items and services | $23.47 | General |
| 11/25/2024 | BIOTISSUE HOLDINGS INC. | — | Food and Beverage | Cash or cash equivalent | $17.75 | General |
| 11/21/2024 | Novo Nordisk Inc | Sogroya (Biological) | Food and Beverage | In-kind items and services | $30.39 | General |
| Category: Growth Hormone | ||||||
| 11/21/2024 | Bayer Healthcare Pharmaceuticals Inc. | Nubeqa (Drug), Xofigo | Food and Beverage | In-kind items and services | $25.52 | General |
| Category: Oncology | ||||||
| 11/20/2024 | Sumitomo Pharma America, Inc. | ORGOVYX (Drug) | Food and Beverage | In-kind items and services | $17.64 | General |
| Category: HORMONE THERAPY | ||||||
| 11/19/2024 | PROGENICS PHARMACEUTICALS, INC. | PYLARIFY (Drug) | Food and Beverage | In-kind items and services | $20.69 | General |
| Category: RADIOPHARMACEUTICAL | ||||||
| 11/16/2024 | Tempus AI, Inc | — | Food and Beverage | In-kind items and services | $100.00 | General |
| 11/14/2024 | Myriad Genetic Laboratories, Inc. | PROLARIS (Device) | Food and Beverage | In-kind items and services | $17.53 | General |
| Category: ONCOLOGY | ||||||
| 11/02/2024 | Medtronic, Inc. | INTERSTIM (Device) | Food and Beverage | In-kind items and services | $35.04 | General |
| Category: Sacral Nerve Stimulation | ||||||
| 10/23/2024 | Endo USA, Inc. | AVEED (Biological), XIAFLEX | Food and Beverage | In-kind items and services | $22.37 | General |
| Category: UROLOGY | ||||||
| 10/21/2024 | Blue Earth Diagnostics Limited | POSLUMA (Drug) | Food and Beverage | In-kind items and services | $22.20 | General |
| Category: Diagnostic Imaging | ||||||
| 10/17/2024 | Janssen Biotech, Inc. | ERLEADA (Drug) | Food and Beverage | In-kind items and services | $20.97 | General |
| Category: Oncology | ||||||
| 10/16/2024 | Sumitomo Pharma America, Inc. | ORGOVYX (Drug) | Food and Beverage | In-kind items and services | $16.99 | General |
| Category: HORMONE THERAPY | ||||||
| 10/15/2024 | Boston Scientific Corporation | SpaceOAR System (Device) | Food and Beverage | In-kind items and services | $140.96 | General |
| Category: Space OAR_URO | ||||||
Research Studies & Clinical Trials
| Study Name | Company | Amount | Records |
|---|---|---|---|
| No Study | COLOPLAST CORP | $53,461 | 6 |
| INTIBIA Pivotal Study | COLOPLAST CORP | $15,895 | 4 |
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 31 | 2,461 | 4,042 | $413,872 | $265,355 |
| 2022 | 28 | 2,248 | 3,416 | $352,849 | $217,720 |
| 2021 | 35 | 2,433 | 3,456 | $335,886 | $208,998 |
| 2020 | 23 | 1,901 | 2,923 | $261,950 | $171,374 |
Total Patients
9,043
Total Services
13,837
Medicare Billing
$863,446
Procedure Codes
123
All Medicare Procedures & Services
123 procedure records from CMS Medicare Utilization — Page 1 of 5
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 404 | 579 | $79,097 | $52,034 | 65.8% |
| 99490 | Chronic care management services, first 20 minutes of clinical staff time directed by health care professional, per calendar month | Office | 2023 | 129 | 871 | $56,432 | $40,251 | 71.3% |
| 55874 | Injection of biodegradable material next to prostate | Office | 2023 | 15 | 15 | $44,988 | $36,096 | 80.2% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2023 | 269 | 333 | $32,198 | $20,371 | 63.3% |
| 99233 | Subsequent hospital care with moderate levelof medical decision making, if using time, at least 50 minutes | Facility | 2023 | 88 | 200 | $24,520 | $18,865 | 76.9% |
| J9217 | Leuprolide acetate (for depot suspension), 7.5 mg | Office | 2023 | 26 | 140 | $25,271 | $18,514 | 73.3% |
| 99204 | New patient office or other outpatient visit, 45-59 minutes | Office | 2023 | 123 | 123 | $22,165 | $13,254 | 59.8% |
| 99232 | Subsequent hospital care with moderate levelof medical decision making, if using time, at least 35 minutes | Facility | 2023 | 71 | 158 | $12,877 | $9,895 | 76.8% |
| 52648 | Complete laser vaporization of prostate including control of bleeding using an endoscope | Facility | 2023 | 16 | 16 | $26,867 | $8,804 | 32.8% |
| 99203 | New patient office or other outpatient visit, 30-44 minutes | Office | 2023 | 88 | 88 | $10,192 | $6,783 | 66.5% |
| 52000 | Diagnostic exam of bladder and urethra using an endoscope | Office | 2023 | 31 | 32 | $8,234 | $5,813 | 70.6% |
| 99222 | Initial hospital care with straightforward or low-level medical decision making, if using time, at least 55 minutes | Facility | 2023 | 52 | 52 | $6,978 | $5,389 | 77.2% |
| 52356 | Crushing of stone of ureter with insertion of stent using an endoscope | Facility | 2023 | 16 | 16 | $6,795 | $5,041 | 74.2% |
| 52000 | Diagnostic exam of bladder and urethra using an endoscope | Facility | 2023 | 69 | 73 | $18,274 | $4,200 | 23.0% |
| 99215 | Established patient office or other outpatient visit, 40-54 minutes | Office | 2023 | 21 | 21 | $3,873 | $2,911 | 75.2% |
| 55700 | Biopsy of prostate gland | Facility | 2023 | 30 | 30 | $7,763 | $2,729 | 35.2% |
| 99221 | Initial hospital care with straightforward or low level of medical decision making, per day, if using time, at least 40 minutes | Facility | 2023 | 26 | 27 | $2,320 | $1,783 | 76.9% |
| 52332 | Insertion of stent in ureter using an endoscope | Facility | 2023 | 13 | 17 | $7,297 | $1,735 | 23.8% |
| 81003 | Automated urinalysis test | Office | 2023 | 502 | 676 | $1,614 | $1,478 | 91.6% |
| 36415 | Insertion of needle into vein for collection of blood sample | Office | 2023 | 119 | 132 | $1,194 | $1,103 | 92.4% |
| 96402 | Administration of hormonal anti-neoplastic chemotherapy under skin or into muscle | Office | 2023 | 31 | 45 | $1,571 | $1,051 | 66.9% |
| 76872 | Ultrasound scan of pelvic region through rectum | Facility | 2023 | 41 | 41 | $1,602 | $986.96 | 61.6% |
| A4648 | Tissue marker, implantable, any type, each | Office | 2023 | 14 | 14 | $2,800 | $953.20 | 34.0% |
| 51798 | Ultrasound measurement of bladder capacity after voiding | Office | 2023 | 118 | 131 | $1,506 | $950.30 | 63.1% |
| 55876 | Placement of device in prostate for radiation therapy | Office | 2023 | 14 | 14 | $2,197 | $881.44 | 40.1% |
About Dr. Lawrence Baum, M.D
Dr. Lawrence Baum, M.D is a Urology healthcare provider based in Houston, Texas. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 06/03/2009. The National Provider Identifier (NPI) number assigned to this provider is 1336375484.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Lawrence Baum, M.D has received a total of $99,104 in payments from pharmaceutical and medical device companies, with $5,026 received in 2024. These payments were reported across 884 transactions from 76 companies. The most common payment nature is "" ($69,356).
As a Medicare-enrolled provider, Baum has provided services to 9,043 Medicare beneficiaries, totaling 13,837 services with total Medicare billing of $863,446. Data is available for 4 years (2020–2023), covering 123 distinct procedure/service records.
Ad
Practice Information
- Specialty Urology
- Location Houston, TX
- Active Since 06/03/2009
- Last Updated 02/16/2011
- Taxonomy Code 208800000X
- Entity Type Individual
- NPI Number 1336375484
Products in Payments
- INTERSTIM (Device) $3,077
- Rezum (Device) $1,792
- XIAFLEX (Biological) $1,576
- XTANDI (Drug) $1,105
- AMS (Device) $755.37
- PROLARIS (Device) $734.68
- NANOKNIFE (Device) $681.29
- SpaceOAR VUE System - 10mL (Device) $666.39
- PROVENGE (Drug) $639.21
- GENERAL BPH (Device) $580.61
- ERLEADA (Drug) $479.87
- Axonics (Device) $477.69
- GEMTESA (Drug) $441.18
- Natesto (Drug) $434.49
- Altis (Device) $421.97
- AMS 700 (Device) $384.52
- BOTOX (Biological) $361.85
- GENERAL KIDNEY STONE DISEASE (Device) $355.23
- XYOSTED (Drug) $335.90
- ALTIS (Device) $335.50
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Urology Doctors in Houston
Donald Griffith, Md, MD
Urology — Payments: $954,139
Urology $954,139
Mohit Khera, M.d, M.D
Urology — Payments: $412,879
Urology $412,879
Dr. Jonathan Clavell Hernandez, Md, MD
Urology — Payments: $402,131
Urology $402,131
Ashish Kamat, M.d, M.D
Urology — Payments: $395,016
Urology $395,016
Run Wang, M.d, M.D
Urology — Payments: $277,432
Urology $277,432
Ouida Westney, M.d, M.D
Urology — Payments: $250,571
Urology $250,571